alzheimer's-disease

alzheimer's-disease

Exploring PD-L1 Antibody Therapy's Role in Reducing Inflammation in Alzheimer's Disease

Recent trial results suggest PD-L1 antibody therapy may reduce inflammation in Alzheimer's, potentially altering disease progression.